AstraZeneca China Chief Under Investigation
AstraZeneca's China President Leon Wang is reportedly under investigation and is cooperating with Chinese authorities. The company has assured that its operations in China will continue under the leadership of the current General Manager. Details on Wang's status remain undisclosed.
AstraZeneca confirmed on Wednesday that Leon Wang, the company's China President, is currently under investigation. Wang is said to be cooperating with Chinese authorities.
The pharmaceutical giant stated that its China operations are continuing without interruption, now led by the current General Manager of AstraZeneca China. The company provided no further information on whether Wang is in government custody.
Inquiries about Wang's location were met with a company spokesperson's confirmation of the investigation, but no additional comments were made.
ALSO READ
-
From Conviction to Innovation: Charles Lieber's Bold Move to China
-
Xi Jinping Advocates Strengthening China's Innovation Edge
-
ANALYSIS-White House quiet as China ramps up trade leverage before Trump-Xi summit
-
China appoints Zhang Zhu agriculture minister in second shake-up in two years
-
EXCLUSIVE-US orders chip equipment companies to halt some shipments to China's No. 2 chipmaker Hua Hong